Figure 4.

WB analysis of plasma SMP30 levels in ALF patients. Plasma from healthy volunteers was used as the control. n = 4 for both groups. SMP30 protein levels in ALF patients were significantly elevated, about 3.65 ± 0.34 times, compared with those in healthy volunteers (P < 0.01).